Vaccines for enterotoxigenic Escherichia coli: current status.
about
Part III. Analysis of data gaps pertaining to enterotoxigenic Escherichia coli infections in low and medium human development index countries, 1984–2005Directed evaluation of enterotoxigenic Escherichia coli autotransporter proteins as putative vaccine candidates.Characterization of heat-stable (STa) toxoids of enterotoxigenic Escherichia coli fused to double mutant heat-labile toxin peptide in inducing neutralizing Anti-STa antibodies.Toxicity and immunogenicity of Enterotoxigenic Escherichia coli heat-labile and heat-stable toxoid fusion 3xSTa(A14Q)-LT(S63K/R192G/L211A) in a murine model.Heat-labile- and heat-stable-toxoid fusions (LTR₁₉₂G-STaP₁₃F) of human enterotoxigenic Escherichia coli elicit neutralizing antitoxin antibodiesModified heat-stable toxins (hSTa) of enterotoxigenic Escherichia coli lose toxicity but display antigenicity after being genetically fused to heat-labile toxoid LT(R192G).Design and characterization of highly immunogenic heat-stable enterotoxin of enterotoxigenic Escherichia coli K99(+).Development of a monoclonal antibody-based co-agglutination test to detect enterotoxigenic Escherichia coli isolated from diarrheic neonatal calvesEnterotoxigenic Escherichia coli elicits immune responses to multiple surface proteins.Ancestral lineages of human enterotoxigenic Escherichia coliContribution of the highly conserved EaeH surface protein to enterotoxigenic Escherichia coli pathogenesis.Importance of heat-labile enterotoxin in colonization of the adult mouse small intestine by human enterotoxigenic Escherichia coli strainsAn adhesion protein of Salmonella enterica serovar Typhi is required for pathogenesis and potential target for vaccine development.Genetic fusions of a CFA/I/II/IV MEFA (multiepitope fusion antigen) and a toxoid fusion of heat-stable toxin (STa) and heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC) retain broad anti-CFA and antitoxin antigenicity.Phylogenetic comparisons reveal multiple acquisitions of the toxin genes by enterotoxigenic Escherichia coli strains of different evolutionary lineages.A tripartite fusion, FaeG-FedF-LT(192)A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibit adherence of K88 (F4) and F18 fimbriae, and protect pigs against K88ac/heat-labile toxin infectionSerum antibodies protect against intraperitoneal challenge with enterotoxigenic Escherichia coliImmune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli.Expression of Escherichia coli virulence usher protein attenuates wild-type SalmonellaProtective Enterotoxigenic Escherichia coli Antigens in a Murine Intranasal Challenge Model.Deletion mutations in N-terminal alpha1 helix render heat labile enterotoxin B subunit susceptible to degradation.Generation of high-titer of neutralizing polyclonal antibodies against heat-stable enterotoxin (STa) of enterotoxigenic Escherichia coliCooperative role of antibodies against heat-labile toxin and the EtpA Adhesin in preventing toxin delivery and intestinal colonization by enterotoxigenic Escherichia coli.Transcriptional modulation of enterotoxigenic Escherichia coli virulence genes in response to epithelial cell interactionsGenotypic characterization of enterotoxigenic Escherichia coli strains causing traveler's diarrhea.The EtpA exoprotein of enterotoxigenic Escherichia coli promotes intestinal colonization and is a protective antigen in an experimental model of murine infection.Transcriptional regulation of subclass 5b fimbriae.A multiepitope fusion antigen elicits neutralizing antibodies against enterotoxigenic Escherichia coli and homologous bovine viral diarrhea virus in vitro.Oral Escherichia coli colonization factor antigen I fimbriae ameliorate arthritis via IL-35, not IL-27.Regulatory T-cell vaccination independent of auto-antigen.More than one way to control hair growth: regulatory mechanisms in enterobacteria that affect fimbriae assembled by the chaperone/usher pathway.Outer membrane vesicles induce immune responses to virulence proteins and protect against colonization by enterotoxigenic Escherichia coli.Genetic fusions of heat-labile (LT) and heat-stable (ST) toxoids of porcine enterotoxigenic Escherichia coli elicit neutralizing anti-LT and anti-STa antibodies.Protection against neonatal enteric colibacillosis employing E. Coli-derived outer membrane vesicles in formulation and without vitamin D3.
P2860
Q29038412-8D1DEAB6-A149-4740-BE5A-CDA9A1E1B4CCQ30155406-48BEA29B-A01E-42F3-B8D0-28D18310D206Q30409778-FF3D8705-12C2-4034-BB78-4DA2692A9FCBQ30416787-AD844200-5963-40E3-BBF6-87387300F953Q30427618-750288E5-393D-4C33-985A-73EA508BB01DQ30429806-0B79EEBF-B957-42CC-981F-688D07377E68Q33806660-2ECFA53C-17C5-44E0-95EA-250B0C5A4E7CQ33860744-F88541E5-9194-4C54-9357-5C37730E1053Q33963134-7DE6939A-1749-4A11-A6DE-6877C4D6B279Q34046378-0EDF42C3-2A70-4EB0-8ADB-22AA02D4BD2BQ34298466-851267ED-BDC0-4BEA-A0B7-2A46AC2A42E3Q34334112-E2CE0114-1719-46B9-A039-BC676AD12354Q34602404-D9E15CEA-D419-402B-B2EE-693257004A32Q35213355-9081CBCB-0B90-4B04-B642-9E4304801057Q35221065-1091AF0B-2E44-42E0-8DB8-39F7AA47EC4DQ35271028-A30C2B52-68A7-4B00-AE28-911FF3DD773AQ35327809-C365ECE3-5FE6-4B9A-9536-FF10263E9AA5Q35689012-B46DC23A-59B3-4AA6-A218-B3B6245A9EE1Q35914147-230FCDA6-B720-41FF-8CB7-BA4F99235712Q35920317-15117AF5-DA55-474A-8201-F039764C9B18Q36092514-10B2B8A0-CC94-4F0D-B734-1BDCD4B5F2A6Q36269155-E87FEFCC-90F9-45F9-A3B1-7D981F6EC770Q36362257-72545CE1-6825-46E7-8ECA-DD0D4034A6A6Q36506158-9A42282C-D195-4F55-8A09-2EB9A48272FAQ36558924-64060A6B-42A6-4B6F-B68C-94375D986122Q36593894-E93594A4-0BD3-440C-9F9B-10D718B4D494Q36964489-98FA8314-54F3-4C87-AD47-97DD571BA128Q36970290-52812074-8D5E-4C41-BE23-79D5365F20A3Q37519964-5BDCFAA3-F4F7-4DFF-83EF-4F2211570200Q37679455-5127342C-267D-4BD5-8CDE-A7910FE73080Q37852489-591A0A65-DCF9-4AFD-A8BF-FB93B794509BQ38955024-79FABA3A-3DF3-4013-9DE7-7C6A8443DBBEQ42947506-3CE9EF66-26FB-4AB9-A3DC-F439E6421EC3Q55262720-7B77736F-7351-4900-83F3-4941BF200066
P2860
Vaccines for enterotoxigenic Escherichia coli: current status.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Vaccines for enterotoxigenic Escherichia coli: current status.
@ast
Vaccines for enterotoxigenic Escherichia coli: current status.
@en
type
label
Vaccines for enterotoxigenic Escherichia coli: current status.
@ast
Vaccines for enterotoxigenic Escherichia coli: current status.
@en
prefLabel
Vaccines for enterotoxigenic Escherichia coli: current status.
@ast
Vaccines for enterotoxigenic Escherichia coli: current status.
@en
P1476
Vaccines for enterotoxigenic Escherichia coli: current status
@en
P2093
Edgar C Boedeker
P577
2005-01-01T00:00:00Z